Your browser doesn't support javascript.
loading
Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.
Nyberg, J; Karlsson, K E; Jönsson, S; Yin, Oqp; Miller, R; Karlsson, M O; Simonsson, Ush.
Afiliação
  • Nyberg J; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Karlsson KE; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Jönsson S; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Yin O; Modeling and Simulation, Translational Medicine, and Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, New Jersey, USA.
  • Miller R; Modeling and Simulation, Translational Medicine, and Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, New Jersey, USA.
  • Karlsson MO; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Simonsson U; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
CPT Pharmacometrics Syst Pharmacol ; 5(4): 222-32, 2016 04.
Article em En | MEDLINE | ID: mdl-27299709
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Piridinas / Tiazóis / Trombose Venosa / Inibidores do Fator Xa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Piridinas / Tiazóis / Trombose Venosa / Inibidores do Fator Xa Idioma: En Ano de publicação: 2016 Tipo de documento: Article